Giscard R. Minlend is the Founder and CEO of ViroVita HealthGlobal LLC, a U.S.-based Web3 healthtech company headquartered in Illinois. With a background in health sciences and a deep focus on patient outcomes and care delivery, Minlend is advancing a decentralized healthcare model built on equity, access, and intelligence. “Healthcare is a fundamental human right,” says Minlend. “Yet more people today are online than have access to essential care.”

Motivated by persistent inequities and inefficiencies in conventional healthcare structures, Minlend launched ViroVita to bridge the growing divide between global connectivity and care access. As AI, blockchain, and decentralized infrastructure reshape global services, ViroVita is building the foundation for borderless, personalized health solutions. At the core of its model is a “Free Core, Premium Tier” approach, offering universally accessible baseline services while enabling advanced, token-powered care experiences. This ecosystem is powered by the ViroVita Token (VVT), a utility token launched on the XRP Ledger to support efficient, low-cost payments, secure data access, and decentralized governance. Designed for both scalability and privacy, VVT enables transparent health transactions while preserving user autonomy through blockchain-based consent. It serves as a backbone for ViroVita’s expanding ecosystem, positioned to empower patients, support providers, and close global health gaps. ViroVita is currently engaging early adopters, mission-aligned investors, and strategic partners across public and private sectors. The company offers SAFE, SAFT, and hybrid investment frameworks, with pilot programs already underway.

To learn more or explore partnerships, visit https://token.virovita.io https://x.com/virovitatoken

ViroVita Token (VVT) audit verification is available on the official website.